Diabetes and Psoriasis: Different Sides of the Same Prism
Rachel Abramczyk,1 Jenna N Queller,2 Amy W Rachfal,3 Stanley S Schwartz4,5 1Main Line Health System, Wynnewood, PA, USA; 2Private Practice, Boca Raton, FL, USA; 3Stage Gate Partners, LLC, Ardmore, PA, USA; 4Stanley Schwartz, LLC, Main Line Health System, Ardmore, PA, USA; 5University of Pennsylvania...
Guardado en:
Autores principales: | Abramczyk R, Queller JN, Rachfal AW, Schwartz SS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/026465d784344851a9b22459c786bef3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
por: Schwartz S
Publicado: (2010) -
Insulin Resistance is Associated with Gut Permeability Without the Direct Influence of Obesity in Young Adults
por: Mkumbuzi L, et al.
Publicado: (2020) -
Associations of Metabolic/Obesity Phenotypes with Insulin Resistance and C-Reactive Protein: Results from the CNTR Study
por: Liao C, et al.
Publicado: (2021) -
The Product of Red Blood Cells and Hematocrit Can Be Used as a Novel Indicator of Impaired Fasting Blood Glucose Status
por: Feng L, et al.
Publicado: (2020) -
Characterization and Treatment of Inflammation and Insulin Resistance in Obese Adipose Tissue
por: Lu Z, et al.
Publicado: (2020)